Today for AI
HOT RADAR
industryHEAT 11.2°

AI CLUSTERED EVENT · 10/14/2026

Science Corp Implants PRIMA Chip in First Stargardt Patient to Expand BCI Vision Restoration

1 reports archived1 independent sourcesupdated 10/14/2026, 07:13:31
Synthesis & Latest Updates
1 Sources Cross-Validated

Science Corporation has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, expanding the technology's application from age-related macular degeneration to inherited eye conditions. CEO Max Hodak redefined retinal prostheses as a form of Brain-Computer Interface (BCI), arguing that such medical implants are essential for extending health span rather than just controlling computers.

LATEST/Science Corporation has implanted its vision-restoring chip, PRIMA, into its first patient with Stargardt disease, expanding the technology's application from age-related macular degeneration to inherited eye conditions. CEO Max Hodak redefined retinal prostheses as a form of Brain-Computer Interface (BCI), arguing that such medical implants are essential for extending health span rather than just controlling computers.

HEAT TRENDHourly heat curve

3 fully observed hours
Now
11.2
Peak
11.808:00
24h change
–

The line compares only sources observed throughout; gap hours are interpolated to keep the trend continuous.

TIMELINECoverage timeline

Total 1 reports · Latest first
  1. TechCrunch AIT2·68 pts
    • PRIMA chip completed its first implantation in a Stargardt disease patient, validating applicability across different blindness mechanisms.
    • Max Hodak proposed a broad definition of BCI, categorizing sensory restoration devices like retinal prostheses and cochlear implants under the same umbrella.
    • The company's strategy shifts towards extending 'health span,' predicting that general populations may require some form of BCI assistance in old age.
Science Corp Implants PRIMA Chip in First Stargardt Patient to Expand BCI Vision Restoration | Today for AI